RxDoctor Payments Data

Jeffrey Kaner, MD

Gastroenterology · Cooper City, FLNPI 1366443947

Payments from drug & device makers

$5,628in general payments, 2019–2025

Across 273 payments — averaging $20.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$856
  • Sanofi$619
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$428
  • QOL Medical, LLC$248
  • Takeda Pharmaceuticals U.S.A., Inc.$243
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$5,628100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,628 in reported general payments places this provider in the 60th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida

Medicare billing

Part B allowed, 2024
$219,148
Medicare patients
477
Services billed
5,101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase13$52,437
LinzessLinaclotide47$42,262
Mesalamine44$17,133
ClenpiqSod Picosulf/Mag Ox/Citric Ac70$11,888
Omeprazole731$8,586
SutabSod Sulf/Pot Chloride/Mag Sulf53$8,544
Pantoprazole Sodium366$5,714
Dexlansoprazole DrDexlansoprazole18$5,153
Ursodiol20$4,261
Colesevelam Hcl12$2,429
Ondansetron Hcl85$1,624
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates17$1,145
Famotidine113$1,075
Dicyclomine Hcl65$1,026
Nortriptyline Hcl25$702

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,195$94,69960 claims
Ferring Pharmaceuticals Inc.Clenpiq$16$11,88870 claims
Braintree Laboratories, Inc.Sutab$33$8,54453 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,388 gastroenterology providers in Florida.

Other gastroenterology in Cooper City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →